Info
Ownership

Mark A. Wilson - Insider Trading & Ownership

Location: 1613 Ray Drive, Burlingame, CA
Summary: The estimated net worth of Mark A. Wilson is at least $540K dollars as of August 21, 2025. Mark A. Wilson is the Chief Legal Officer of NEKTAR THERAPEUTICS and owns shares of NEKTAR THERAPEUTICS (NKTR) stock worth about $540K.
Signature: Mark A. Wilson
All Insider Reports: All Insider Reports

Ownership of Mark A. Wilson

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
NKTR	NEKTAR THERAPEUTICS	Chief Legal Officer	$540K	-$87.1K	-13.9%	Aug 19, 2025

Showing 1 to 1 of 1 entries

Insider Transactions Reported by Mark A. Wilson:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
NKTR	Nektar Therapeutics	Common Stock	Sale	-3.22%	-$18K	26.59	-676	20.3K	8/19/2025	Direct
NKTR	Nektar Therapeutics	Stock Option	Award		$0	0.00	+21.7K	21.7K	8/19/2025	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-3.08%	-$6.7K	0.67	-10K	314K	5/19/2025	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-3.29%	-$11.2K	1.01	-11K	324K	2/19/2025	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-4.71%	-$14.7K	0.89	-16.6K	335K	12/24/2024	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-8.67%	-$30.1K	0.90	-33.4K	352K	12/23/2024	Direct
NKTR	Nektar Therapeutics	Common Stock	Award	+75.7%	$0	0.00	+166K	385K	12/13/2024	Direct
NKTR	Nektar Therapeutics	Stock Option	Award		$0	0.00	+657K	332K	12/13/2024	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-2.84%	-$6.47K	1.01	-6.41K	219K	11/19/2024	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-2.45%	-$7.23K	1.28	-5.65K	225K	8/19/2024	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-2.64%	-$11K	1.75	-6.26K	230K	5/17/2024	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-3.11%	-$5.17K	0.68	-7.61K	237K	2/20/2024	Direct
NKTR	Nektar Therapeutics	Stock Option	Award		$0	0.00	+325K	325K	12/13/2023	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-2.86%	-$3.52K	0.49	-7.18K	244K	11/17/2023	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-2.8%	-$5.63K	0.78	-7.22K	251K	8/16/2023	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-2.84%	-$5.43K	0.72	-7.54K	258K	5/16/2023	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-3.03%	-$24.8K	3.00	-8.28K	265K	2/16/2023	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-3.09%	-$31K	3.57	-8.69K	272K	11/16/2022	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-1.12%	-$15.2K	4.76^*	-3.19K	281K	8/16/2022	Direct
NKTR	Nektar Therapeutics	Common Stock	Award	+140.1%	$0	0.00	+166K	284K	8/15/2022	Direct
NKTR	Nektar Therapeutics	Common Stock	Award		$0	0.00	+332K	332K	8/15/2022	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-2.59%	-$12.4K	3.95	-3.14K	118K	5/16/2022	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-2.93%	-$40.1K	10.95^*	-3.66K	121K	2/16/2022	Direct
NKTR	Nektar Therapeutics	Common Stock	Award	+43.5%	$0	0.00	+37.8K	125K	12/16/2021	Direct
NKTR	Nektar Therapeutics	Stock Option	Award		$0	0.00	+67.2K	67.2K	12/16/2021	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-7.06%	-$86.4K	13.16^*	-6.56K	86.4K	11/16/2021	Direct
NKTR	Nektar Therapeutics	Common Stock	Award	+27.6%	$0	0.00	+20.1K	93K	11/15/2021	Direct
NKTR	Nektar Therapeutics	Stock Option	Award		$0	0.00	+35.8K	35.8K	10/12/2021	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-2.55%	-$26.4K	13.83^*	-1.91K	72.9K	8/16/2021	Direct
NKTR	Nektar Therapeutics	Common Stock	Sale	-2.5%	-$35.1K	18.30^*	-1.92K	74.8K	5/17/2021	Direct

Previous1Next

Showing 1 to 30 of 30 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.